Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure

Circulation

Volumn 97, Issue 23, 1998, Pages 2316-2322

  Dipla, Konstantina ^a   Mattiello, Julian A ^a   Jeevanandam, Valluvan ^a   Houser, Steven R ^a   Margulies, Kenneth B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Cardiomyopathy; Heart assist device; Myocytes

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EXTRACORPOREAL CIRCULATION; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032537621     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.23.2316     Document Type: Article

References (39)

1. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features, and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565-1574. Review.
2. Om A, Hess ML. Inotropic therapy of the failing myocardium. Clin Cardiol. 1993;16:5-14. Review.
3. Bristow MR, Sandoval AB, Gilbert EM, Dersher T, Minobe W, Rasmussen R. Myocardial α- and β-adrenergic receptors in heart failure: is cardiac derived norepinephrine the regulatory signal? Eur Heart J. 1988;9:35-40.
4. Bristow MR, Hershberger RE, Port JD, Rasmussen R. α- and β2-adrenergic receptor mediated adenylate cyclase stimulation in non-failing and failing human ventricular myocardium. Mol Pharmacol. 1989;35:295-303.
5. Brodde OH, Zerkowski HR, Doetsch N, Motomura S, Khamssi M, Michel MC. Myocardial beta adrenoreceptor changes in heart failure: concomitant reduction in beta1 and beta2 adrenoreceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol. 1989;14:323-331.
6. Bristow MR, Feldman AM. Changes in the receptor-G protein-adenylyl cyclase system in heart from various types of heart muscle disease. Basic Res Cardiol. 1991:86(suppl 1):15-35.
7. Brodde OE, β1 and β2 adrenoreceptors in the human heart: properties, function and alterations in chronic heart failure. Pharmacol Rev. 1991;43:204-242.
8. Ginsburg R, Bristow M, Billingham ME, Stinson EB, Schroeder J, Harrison DC. Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. Am Heart J. 1983;106:535-540.
9. Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA. Harding SE. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation. 1995;92:2540-2549.
10. Mulieri LA, Hasenfuss G, Leavitt B, Allen P, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation. 1992;85:1743-1750.
11. ACC/AHA Task Force. Guidelines for evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376-1398.
12. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293-302.
13. Cohn JN, Johnson GM, Ziesche SR, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Blat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med. 1991;325:303-310.
14. Reddy S, Benatar D, Gheorgiade M. Update on digoxin and other oral positive inotropic agents for chronic heart failure. Curr Opin Cardiol. 1997;12:233-241. Review.
15. Batista RJ, Santos JL, Takeshita N, Bocchino L, Lima PN, Cunha MA. Partial left ventriculectomy to improve left ventricular function in the end-stage heart disease. J Cardiac Surg. 1996;11:96-97.
16. Gojo S, Kitamura S, Katano O, Takakusu A, Hashimoto K, Kanagae Y, Saito I. Transplantation of genetically marked cardiac muscle cells. J Thorac Cardiovasc Surg. 1997;113:10-18.
17. Li RK, Jia ZQ, Weisel RD, Mickle DA, Zhang J, Mohabeer MK, Rao V, Ivanov J. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg. 1996;62:654-660.
18. Altemose GT, Gritsus V, Jeevanandam V, Goldman B, Margulies KB. Altered myocardial phenotype following mechanical support in humans with advanced cardiomyopathy. J Heart Lung Transplant. 1997;16:765-771.
19. ++ current in severely hypertrophied feline ventricular myocytes. J Mol Cell Cardiol. 1991;23:717-726.
20. Bailey BA, Houser SR. Calcium transients in feline left ventricular myocytes with hypertrophy induced by slow progressive pressure overload. J Mol Cell Cardiol. 1992;24:365-373.
21. Bailey BA, Houser SR. Sarcoplasmic reticulum-related changes in cytosolic calcium in pressure-overload-induced feline left ventricular hypertrophy. Am J Physiol. 1993;265:H2009-H2026.
22. Hasenfuss G, Holubarsch C, Just H, Alpert NR. Cellular and molecular alterations in the failing human heart. Basic Res Cardiol. 1992;87(suppl 1):9-18.
23. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Haeberle JR, Alpert NR. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res. 1992;70:1225-1232.
24. Hasenfuss G, Just H. Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significance. Br Heart J. 1994;72(suppl 2):S10-S17.
25. Frazier OH, Rose EA, Macmanus Q, Burton N, Lefrac E, Poirier V, Dasse K. Multicenter clinical evaluation of the Heartmate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53:1088-1090.
26. Frazier OH. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation. 1994;89:2908-2914.
27. Nakatani S, McCarthy P, Kottke-Marchant K, Harasaki H, James K, Savage R, Thomas J. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol. 1996;27:894-901.
28. Levin HR, Oz CM, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 1995;91:2717-2720.
29. Zafeiridis A, Houser SR, Mattiello JA, Jeevanandam V, Margulies KB. LVAD support produces reverse remodeling of cardiac myocytes. Circulation. 1997;96(suppl I):I-603. Abstract.
30. Tomanek RJ, Cooper G IV. Morphological changes in the mechanically unloaded myocardial cell. Anat Rec. 1981;200:271-280.
31. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-469.
32. Alpert NR, Periasamy M, Arai M, Matsiu H, Mulieri LA, Hasenfuss G. The regulation of calcium cycling in stressed hearts. Basic Res Cardiol. 1992;87(suppl 2):71-80.
33. ++] handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J. 1995;129:684-689.
34. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 1995;92:1169-1178.
35. Bohm M. Alterations of β-adrenoreceptor-G-protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem. 1995;147:147-160.
36. Covell JW, Chidsey CA, Braunwald E. Reduction in the cardiac response to postganglionic sympathetic nerve stimulation in experimental heart failure. Circ Res. 1966;19:51-66.
37. Feldman AM. Modulation of adrenoreceptors and G transduction proteins in failing human ventricular myocardium. Circulation. 1993;87(suppl IV):IV-27-IV-34.
38. Bristow MR, Ginsburg R, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Stinson E. β1 and β2 adrenergic receptor subpopulations in normal and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1 receptor downregulation in heart failure. Circ Res. 1986;59:297-309.
39. Levin HR, Chen JM, Oz MC, Catanese KA, Krum H, Goldsmith RL, Packer M, Rose EA. Potential for left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg. 1994;58:1515-1520.